Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2022-05-02 History
Report ID 147629
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CALCIUM GLUCONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 mL
ATC code B05BB
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-01-01
Actual start date 2022-03-01
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-05-02
Company comments Effective May. 2, 2022, will be placed on allocation. Contract customers will be allocated 100% historical monthly demand.
Health Canada comments
Tier 3 Status Yes
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2022-05-02 French Compare
v26 2022-05-02 English Compare
v25 2022-03-14 English Compare
v24 2022-03-04 French Compare
v23 2022-03-04 English Compare
v22 2022-03-02 English Compare
v21 2022-02-28 French Compare
v20 2022-02-28 English Compare
v19 2022-02-08 French Compare
v18 2022-02-08 English Compare
v17 2022-02-04 French Compare
v16 2022-02-04 English Compare
v15 2022-01-24 French Compare
v14 2022-01-24 English Compare
v13 2022-01-02 English Compare
v12 2021-12-24 French Compare
v11 2021-12-24 English Compare
v10 2021-12-08 French Compare
v9 2021-12-08 English Compare
v8 2021-11-16 French Compare

Showing 1 to 20 of 27